Taxonomic reappraisal of the sphagesaurid crocodyliform Sphagesaurus montealtensis from the Late Cretaceous Adamantina Formation of São Paulo State, Brazil

Iori, Fabiano Vidoi, Marinho, Thiago Da Silva, Carvalho, Ismar De Souza, Campos, Antonio Celso De Arruda (2013): Taxonomic reappraisal of the sphagesaurid crocodyliform Sphagesaurus montealtensis from the Late Cretaceous Adamantina Formation of São Paulo State, Brazil. Zootaxa 3686 (2): 183-200, DOI: 10.11646/zootaxa.3686.2.

Tafonomia de moluscos fósseis do Grupo Bauru (Cretáceo Superior, Bacia Bauru), na região do município de Monte Alto, São Paulo, Brasil

Bivalves mollusks fossils of Bauru Group (Late Cretaceous, Bauru Basin) deposited in scientific collections and collected in outcrops from Monte Alto municipality, São Paulo, are analyzed in their taphonomy. The preservation of recrystallized individual in carbonatic matrix indicates substrate remobilization by unidirectional energetic event in fluvial discharge. The specimens with conjugated valves possess internal sediment similar to the external indicating low exposition to Taphonomical Active Zone, suggesting a bioclastic low time-averaging. The truncate and fragmented posterior portion of specimens from scientific collections is probably related to the incapacity of the taxa to reburrowing the substrate in drowning periods. Both taphonomic patterns corroborate evidences of a fluvial paleoenvironment in the Bauru Group

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN